Polymeric protein delivery systems

Progress in Polymer Science (Oxford)

Volumn 32, Issue 7, 2007, Pages 669-697

  Lee, Kuen Yong ^a   Yuk, Soon Hong ^b  

^a Hanyang University   (South Korea)

^b Hannam University   (South Korea)

Author keywords

Biocompatible polymer; Hydrogel; Liposome; Protein delivery; Tissue engineering

Indexed keywords

BIOCOMPATIBILITY; DRUG DELIVERY; HYDROGELS; LIPOSOMES; POLYMERS; TISSUE ENGINEERING;

ENZYMATIC DEGRADATION; HALF-LIFE; POLYMERIC CARRIERS;

PROTEINS;

EID: 34250805948     PISSN: 00796700     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.progpolymsci.2007.04.001     Document Type: Review

References (249)

1. Tabata Y., and Ikada Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 31 (1998) 287-301
2. Manning M.C., Patel K., and Borchardt T. Stability of protein pharmaceuticals. Pharm Res 6 (1989) 903-918
3. Prokop A., Kozlov E., Carlesso G., and Davidson J.M. Hydrogel-based colloidal polymeric system for protein and drug delivery: physical and chemical characterization, permeability control and applications. Adv Polym Sci 160 (2002) 119-173
4. Tanaka Y., Gong J.P., and Osada Y. Novel hydrogels with excellent mechanical performance. Prog Polym Sci 30 (2005) 1-9
5. Varghese S., and Elisseeff J H. Hydrogels for musculoskeletal tissue engineering. Adv Polym Sci 203 (2006) 95-144
6. Lee K Y., and Mooney D.J. Hydrogels for tissue engineering. Chem Rev 101 (2001) 1869-1879
7. Sakiyama-Elbert S.E., and Hubbell J.A. Functional biomaterials: design of novel biomaterials. Annu Rev Mater Res 31 (2001) 183-201
8. Rault I., Frei V., Herbage D., Abdul-Malak N., and Huc A. Evaluation of different chemical methods for cross-linking collagen gel, films and sponges. J Mater Sci Mater Med 7 (1996) 215-221
9. Chevallay B., Abdul-Malak N., and Herbage D. Mouse fibroblasts in long-term culture within collagen three-dimensional scaffolds: influence of cross-linking with diphenylphosphorylazide on matrix reorganization, growth, and biosynthetic and proteolytic activities. J Biomed Mater Res 49 (1999) 448-459
10. Inoue N., Bessho M., Furuta M., Kojima T., Okuda S., and Hara M. A novel collagen hydrogel cross-linked by γ-ray irradiation in acidic pH conditions. J Biomater Sci Polym Ed 17 (2006) 837-858
11. Pulapura S., and Kohn J. Trends in the development of bioresorbable polymers for medical applications. J Biomater Appl 6 (1992) 216-250
12. Tabata Y., Miyao M., Ozeki M., and Ikada Y. Controlled release of vascular endothelial growth factor by use of collagen hydrogels. J Biomater Sci Polym Ed 11 (2000) 915-930
13. Asghar A., and Henrickson R.L. Chemical, biochemical, functional, and nutritional characteristics of collagen in food systems. Adv Food Res 28 (1982) 231-372
14. Kuijpers A.J., Engbers G.H.M., Feijen J., De Smedt S.C., Meyvis T.K.L., Demeester J., et al. Characterization of the network structure of carbodiimide cross-linked gelatin gels. Macromolecules 32 (1999) 3325-3333
15. Choi Y.S., Hong S.R., Lee Y.M., Song K.W., Park M.H., and Nam Y.S. Study on gelatin-containing artificial skin: I. Preparation and characteristics of novel gelatin-alginate sponge. Biomaterials 20 (1999) 409-417
16. Hellio D., and Djabourov M. Physically and chemically cross-linked gelatin gels. Macromol Symp 241 (2006) 23-27
17. Bessho M., Furuta M., Kojima T., Okuda S., and Hara M. Gelatin hydrogels cross-linked by gamma-ray irradiation: materials for absorption and release of dye. J Biomater Sci Polym Ed 16 (2005) 715-724
18. Ozeki M., and Tabata Y. in vivo degradability of hydrogels prepared from different gelatins by various cross-linking methods. J Biomater Sci Polym Ed 16 (2005) 549-561
19. Yamamoto M., Tabata Y., and Ikada Y. Growth factor release from gelatin hydrogel for tissue engineering. J Bioact Compat Polym 14 (1999) 474-489
20. Young S., Wong M., Tabata Y., and Mikos A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Rel 109 (2005) 256-274
21. Okino H., Nakayama Y., Tanaka M., and Matsuda T. In situ hydrogelation of photocurable gelatin and drug release. J Biomed Mater Res 59 (2002) 233-245
22. Konishi M., Tabata Y., Kariya M., Suzuki A., Mandai M., Nanbu K., et al. in vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J Control Rel 92 (2003) 301-313
23. Laurens N., Koolwijk P., and De Maat M.P.M. Fibrin structure and wound healing. J Thromd Haemost 4 (2006) 932-939
24. Perka C., Spitzer R.S., Lindenhayn K., Sittinger M., and Schultz O. Matrix-mixed culture: new methodology for chondrocyte culture and preparation of cartilage transplants. J Biomed Mater Res 49 (2000) 305-311
25. Ye Q., Zund G., Benedikt P., Jockenhoevel S., Hoerstrup S.P., Sakyama S., et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 17 (2000) 587-591
26. Gwak S.J., Kim S.S., Sung K., Han J.H., Choi C.Y., and Kim B.S. Synergistic effect of keratinocyte transplantation and epidermal growth factor delivery on epidermal regeneration. Cell Transplant 14 (2005) 809-817
27. Geer D.J., Swartz D.D., and Andreadis S.T. Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am J Pathol 167 (2005) 1575-1586
28. Jung R.E., Schmoekel H.G., Zwahlen R., Kokovic V., Hammerle C.H.F., and Weber F.E. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2. Clin Oral Implant Res 16 (2005) 676-682
29. Schmoekel H.G., Weber F.E., Schense J.C., Gratz K.W., Schawalder P., and Hubbell J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng 89 (2005) 253-262
30. Kelpke S.S., Zinn K.R., Rue L.W., and Thompson J.A. Site-specific delivery of acidic fibroblast growth factor stimulates angiogenic and osteogenic responses in vivo. J Biomed Mater Res A 71A (2004) 316-325
31. Price R.D., Myers S., Leigh I.M., and Navsaria H.A. The role of hyaluronic acid in wound healing-assessment of clinical evidence. Am J Clin Dermatol 6 (2005) 393-402
32. Arimura H., Ouchi T., Kishida A., and Ohya Y. Preparation of a hyaluronic acid hydrogel through polyion complex formation using cationic polylactide-based microspheres as a biodegradable cross-linking agent. J Biomater Sci Polym Ed 16 (2005) 1347-1358
33. Shu X.Z., Liu Y.C., Luo Y., Roberts M.C., and Prestwich G.D. Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules 3 (2002) 1304-1311
34. Vercruysse K.P., Marecak D.M., Marecek J.F., and Prestwich G.D. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjugate Chem 8 (1997) 686-694
35. Inukai M., Jin Y., Yomota C., and Yonese M. Preparation and characterization of hyaluronate-hydroxyethyl acrylate blend hydrogel for controlled release device. Chem Pharm Bull 48 (2000) 850-854
36. Leach J.B., and Schmidt C.E. Characterization of protein release from photo-cross-linkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds. Biomaterials 26 (2005) 125-135
37. Hahn S.K., and Hoffman A.S. Preparation and characterization of biocompatible polyelectrolyte complex multilayer of hyaluronic acid and poly-l-lysine. Int J Biol Macromol 37 (2005) 227-231
38. Ruhela D., Riviere K., and Szoka F.C. Efficient synthesis of an aldehyde functionalized hyaluronic acid and its application in the preparation of Hyaluronan-lipid conjugates. Bioconjugate Chem 17 (2006) 1360-1363
39. Zhao X. Synthesis and characterization of a novel hyaluronic acid hydrogel. J Biomater Sci Polym Ed 17 (2006) 419-433
40. Choi Y.S., Hong SR., Lee Y.M., Song K.W., Park M.H., and Nam Y.S. Studies on gelatin-containing artificial skin: II. Preparation and characterization of cross-linked gelatin-hyaluronate sponge. J Biomed Mater Res 48 (1999) 631-639
41. Ji Y., Ghosh K., Shu X.Z., Li B.Q., Sokolov J.C., Prestwich G.D., et al. Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds. Biomaterials 27 (2006) 3782-3792
42. Ng K.W., Tham W., Lim T.C., and Hutmacher D.W. Assimilating cell sheets and hybrid scaffolds for dermal tissue engineering. J Biomed Mater Res A 75A (2005) 425-438
43. Afify A.M., Stern M., Guntenhoner M., and Stern R. Purification and characterization of human serum hyaluronidase. Arch Biochem Biophys 305 (1993) 434-441
44. Segura T., Anderson B.C., Chung P.H., Webber R.E., Shull K.R., and Shea L.D. Cross-linked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials 26 (2005) 359-371
45. Bulpitt P., and Aeschlimann D. New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res 47 (1999) 152-169
46. George M., and Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J Control Rel 114 (2006) 1-14
47. Augst A.D., Kong H.J., and Mooney D.J. Alginate hydrogels as biomaterials. Macromol Biosci 6 (2006) 623-633
48. Lee K.Y., Rowley J.A., Eiselt P., Moy E.M., Bouhadir K.H., and Mooney D.J. Controlling mechanical and swelling properties of alginate hydrogels independently by cross-linker type and cross-linking density. Macromolecules 33 (2000) 4291-4294
49. Bouhadir K.H., Hausman D.S., and Mooney D.J. Synthesis and mechanical properties of cross-linked poly(aldehyde guluronate) hydrogels. Polymers 40 (1999) 3575-3584
50. Al-Shamkhani A., and Duncan R. Radioiodination of alginate via covalently-bound tyrosinamide allows for monitoring of its fate in vivo. J Bioact Compat Polym 10 (1995) 4-13
51. Bouhadir K.H., Lee K.Y., Alsberg E., Damm K.L., Anderson K.W., and Mooney D.J. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Progr 17 (2001) 945-950
52. Kong H.J., Kaigler D., Kim K., and Mooney D.J. Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. Biomacromolecules 5 (2004) 1720-1727
53. Atala A., Kim W., Paige K.T., Vacanti C.A., and Retik A.B. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J Urol 152 (1994) 641-643
54. Gombotz WR., and Wee S.F. Protein release from alginate matrices. Adv Drug Deliv Rev 31 (1998) 267-285
55. Silva C.M., Ribeiro A.J., Figueiredo I.V., Goncalves A.R., and Veiga F. Alginate microspheres prepared by internal gelation: development and effect on insulin stability. Int Pharm 311 (2006) 1-10
56. Luginbuehl V., Wenk E., Koch A., Gander B., Merkle H.P., and Meinel L. Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration. Pharm Res 22 (2005) 940-950
57. Westhaus E., and Messersmith P.B. Triggered release of calcium from lipid vesicles: a bioinspired strategy for rapid gelation of polysaccharide and protein hydrogels. Biomaterials 22 (2001) 453-462
58. Singh D.K., and Ray A.R. Biomedical applications of chitin, chitosan, and their derivatives. J Macromol Sci Rev Macromol Chem Phys C40 (2000) 69-83
59. Rinaudo M. Chitin and chitosan: properties and applications. Progr Polym Sci 31 (2006) 603-632
60. Chenite A., Chaput C., Wang D., Combes C., Buschmann M.D., Hoemann C.D., et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21 (2000) 2155-2161
61. Lin Y.H., Liang H.F., Chung C.K., Chen M.C., and Sung H.W. Physically cross-linked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials 26 (2005) 2105-2113
62. Mi F.L., Kuan C.Y., Shyu S.S., Lee S.T., and Chang S.F. The study of gelation kinetics and chain-relaxation properties of glutaraldehyde-cross-linked chitosan gel and their effects on microspheres preparation and drug release. Carbohydr Polym 41 (2000) 389-396
63. Ono K., Saito Y., Yura H., Ishikawa K., Kurita A., Akaike T., et al. Photocrosslinkable chitosan as a biological adhesive. J Biomed Mater Res 49 (2000) 289-295
64. Bhattarai N., Ramay H.R., Gunn J., Matsen F.A., and Zhang M.Q. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J Control Rel 103 (2005) 609-624
65. Kofuji K., Murata Y., and Kawashima S. Sustained insulin release with biodegradation of chitosan gel beads prepared by copper ions. Int J Pharm 303 (2005) 95-103
66. Kofuji K., Akamine H., Oshirabe H., Maeda Y., Murata Y., and Kawashima S. Retention and release behavior of insulin in chitosan gel beads. J Biomater Sci Polym Ed 14 (2003) 1243-1253
67. Fujita M., Ishihara M., Morimoto Y., Simizu M., Saito Y., Yura H., et al. Efficacy of photo-cross-linkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction. J Surg Res 126 (2005) 27-33
68. Crepon B., Jozefonvicz J., Chytry V., Rihova B., and Kopecek J. Enzymic degradation and immunogenic properties of derivatized dextrans. Biomaterials 12 (1991) 550-554
69. van Dijk-Wolthuis W.N.E., Hoogeboom J.A.M., van Steenbergen M.J., Tsang S.K.Y., and Hennink W.E. Degradation and release behavior of dextran-based hydrogels. Macromolecules 30 (1997) 4639-4645
70. Franssen O., Vandervennet L., Roders P., and Hennink W.E. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. J Control Rel 60 (1999) 211-221
71. Cadee J.A., de Groot C.J., Jiskoot W., den Otter W., and Hennink W.E. Release of recombinant human interleukin-2 from dextran-based hydrogels. J Control Rel 78 (2002) 1-13
72. van Tomme S.R., van Nostrum C.F., de Smedt S.C., and Hennink W.E. Degradation behavior of dextran hydrogels composed of positively and negatively charged microspheres. Biomaterials 27 (2006) 4141-4148
73. Zalipsky S. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjugate Chem 6 (1995) 150-165
74. Chae S.Y., Kim S.W., and Bae Y.H. Bioactive polymers for biohybrid artificial pancreas. J Drug Target 9 (2001) 473-484
75. Lim C.J., and Shen W.C. Transferrin-oligomers as potential carriers in anticancer drug delivery. Pharm Res 21 (2004) 1985-1992
76. Castellanos I.J., Crespo R., and Griebenow K. Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. J Control Rel 88 (2003) 135-145
77. Castellanos I.J., Flores G., and Griebenow K. Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on α-chymotrypsin stability upon encapsulation in PLGA microspheres. J Pharm Pharmacol 57 (2005) 1261-1269
78. Sofia S.J., Premnath V.V., and Merrill E.W. Poly(ethylene oxide) grafted to silicon surfaces: grafting density and protein adsorption. Macromolecules 31 (1998) 5059-5070
79. Jovanovic A.V., Flint J.A., Varshney M., Morey T.E., Dennis D.M., and Duran R.S. Surface modification of silica core-shell nanocapsules: biomedical implications. Biomacromolecules 7 (2006) 945-949
80. Jones J.A., Dadsetan M., Collier T.O., Ebert M., Stokes K.S., Ward R.S., et al. Macrophage behavior on surface-modified polyurethanes. J Biomater Sci Polym Ed 15 (2004) 567-584
81. Andreopoulos F.M., Deible C.R., Stauffer M.T., Weber S.G., Wagner W.R., Beckman E.J., et al. Photoscissable hydrogel synthesis via rapid photopolymerization of novel PEG-based polymers in the absence of photoinitiators. J Am Chem Soc 118 (1996) 6235-6240
82. Zhao X., and Harris J.M. Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein. J Pharm Sci 87 (1998) 1450-1458
83. Peppas N.A., Keys K.B., Torres-Lugo M., and Lowman A.M. Poly(ethylene glycol)-containing hydrogels in drug delivery. J Control Rel 62 (1999) 81-87
84. Lopina S.T., Wu G., Merrill E.W., and Griffith-Cima L. Hepatocyte culture on carbohydrate-modified star polyethylene oxide hydrogels. Biomaterials 17 (1996) 559-569
85. Zhang L., Furst E.M., and Kiick K.L. Manipulation of hydrogel assembly and growth factor delivery via the use of peptide-polysaccharide interactions. J Control Rel 114 (2006) 130-142
86. Ferretti M., Marra K.G., Kobayashi K., Defail A.J., and Chu C.R. Controlled in vivo degradation of genipin cross-linked polyethylene glycol hydrogels within osteochondral defects. Tissue Eng 12 (2006) 2657-2663
87. Sperinde J.J., and Griffith L.G. Synthesis and characterization of enzymatically cross-linked poly(ethylene glycol) hydrogels. Macromolecules 30 (1997) 5255-5264
88. Mellott M.B., Searcy K., and Pishko M.V. Release of protein from highly cross-linked hydrogels of poly(ethylene glycol) diacrylate fabricated by UV polymerization. Biomaterials 22 (2001) 929-941
89. Gombotz W R., and Pettit D K. Biodegradable polymers for protein and peptide drug delivery. Bioconjugate Chem 6 (1995) 332-351
90. Harada A., and Kataoka K. Chain length recognition: core-shell supramolecular assembly from oppositely charged block copolymers. Science 283 (1999) 65-67
91. Alakhov V.Y., Moskaleva E.Y., Batrakova E.V., and Kabanov A.V. Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 block copolymer. Bioconjugate Chem 7 (1996) 209-216
92. Wang B., Zhu W., Zhang Y., Yang Z.G., and Ding J.D. Synthesis of a chemically cross-linked thermo-sensitive hydrogel film and in situ encapsulation of model protein drugs. React Funct Polym 66 (2006) 509-518
93. Lee H.T., and Lee D.S. Thermoresponsive phase transitions of PLA-block-PEO-block-PLA triblock stereo-copolymers in aqueous solution. Macromol Res 10 (2002) 359-364
94. Lee J.Y., Cho E.C., and Cho K. Incorporation and release behavior of hydrophobic drug in functionalized poly(d,l-lactide)-block-poly(ethylene oxide) micelles. J Control Rel 94 (2004) 323-335
95. Molina I., Li S.M., and Martinez M.B. Vert M Protein release from physically cross-linked hydrogels of the PLA/PEO/PLA triblock copolymer-type. Biomaterials 22 (2001) 363-369
96. Jeong B., Bae Y.H., Lee D.S., and Kim S.W. Biodegradable block copolymers as injectable drug-delivery systems. Nature 388 (1997) 860-862
97. Jeong B., Choi Y.K., Bae Y.H., Zentner G., and Kim S.W. New biodegradable polymers for injectable drug delivery systems. J Control Rel 62 (1999) 109-114
98. Yamaguchi N., and Kiick K.L. Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels. Biomacromolecules 6 (2005) 1921-1930
99. van de Wetering P., Metters A.T., Schoenmakers R.G., and Hubbell J.A. Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins. J Control Rel 102 (2005) 619-627
100. Martens P.J., Bryant S.J., and Anseth K.S. Tailoring the degradation of hydrogels formed from multivinyl poly(ethylene glycol) and poly(vinyl alcohol) macromers for cartilage tissue engineering. Biomacromolecules 4 (2003) 283-292
101. Brown C.D., Stayton P.S., and Hoffman A.S. Semi-interpenetrating network of poly(ethylene glycol) and poly(d,l-lactide) for the controlled delivery of protein drugs. J Biomater Sci Polym Ed 16 (2005) 189-201
102. Ende M.T.A., and Peppas N.A. Transport of ionizable drugs and proteins in cross-linked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. 2. Diffusion and release studies. J Control Rel 48 (1997) 47-56
103. Oh K.T., Bronich T.K., Kabanov V.A., and Kabanov A.V. Block polyelectrolyte networks from poly(acrylic acid) and poly(ethylene oxide): sorption and release of cytochrome C. Biomacromolecules 8 (2007) 490-497
104. Yin L.C., Fei L.K., Cui F.Y., Tang C., and Yin C.H. Superporous hydrogels containing poly(acrylic acid-co-acrylamide)/O-carboxymethyl chitosan interpenetrating polymer networks. Biomaterials 28 (2007) 1258-1266
105. Foss A.C., and Peppas N.A. Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with CaCO-2 cultures. Eur J Pharm Biopharm 57 (2004) 447-455
106. Cleary J., Bromberg L.E., and Magner E. Diffusion and release of solutes in pluronic-g-poly(acrylic acid) hydrogels. Langmuir 19 (2003) 9162-9172
107. Obaidat A.A., and Park K. Characterization of glucose dependent gel-sol phase transition of the polymeric glucose-concanavalin A hydrogel system. Pharm Res 13 (1996) 989-995
108. Nagahara S., and Matsuda T. Hydrogel formation via hybridization of oligonucleotides derivatized in water-soluble vinyl polymers. Polym Gels Networks 4 (1996) 111-127
109. Wang C., Stewart R.J., and Kopecek J. Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature 397 (1999) 417-420
110. Wu J.Y., Liu S.Q., Heng P.W.S., and Yang Y.Y. Evaluating proteins release from, and their interactions with, thermosensitive poly (N-isopropylacrylamide) hydrogels. J Control Rel 102 (2005) 361-372
111. Zhang J.T., Huang S.W., Cheng S.X., and Zhuo R.X. Preparation and properties of poly(N-isoproplyacrylamide)/poly(N-isopropylacrylamide) interpenetrating polymer networks for drug delivery. J Polym Sci Polym Chem Ed 42 (2004) 1249-1254
112. Heskins M., and Guillet J.E. Solution properties of poly(N-isopropylacrylamide). J Macromol Sci Chem Ed A2 (1968) 1441-1449
113. Stile R.A., Burghardt W.R., and Healy K.E. Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro. Macromolecules 32 (1999) 7370-7379
114. Brazel C.S., and Peppas N.A. Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels. J Control Rel 39 (1996) 57-64
115. Bromberg L.V., and Ron E.S. Protein and peptide release from temperature-responsive gels and thermogelling polymer matrices. Adv Drug Deliv Rev 31 (1998) 197-221
116. Huh K.M., Hashi J., Ooya T., and Yui N. Synthesis and characterization of dextran grafted with poly(N-isopropylacrylamide-co-N,N-dimethyl-acrylamide). Macromol Chem Phys 201 (2000) 613-619
117. Nakamae K., Nishino T., Kato K., Miyata T., and Hoffman A.S. Synthesis and characterization of stimuli-sensitive hydrogels having a different length of ethylene glycol chains carrying phosphate groups: loading and release of lysozyme. J Biomater Sci Polym Ed 15 (2004) 1435-1446
118. Cheng S.X., Zhang J.T., and Zhuo R.X. Macroporous poly(N-isopropylacrylamide) hydrogels with fast response rates and improved protein release properties. J Biomed Mater Res A 67A (2003) 96-103
119. Hassan C.M., and Peppas N.A. Structure and applications of poly(vinyl alcohol) hydrogels produced by conventional cross-linking or by freezing/thawing methods. Adv Polym Sci 153 (2000) 37-65
120. Park J.S., Park J.W., and Ruckenstein E. Thermal and dynamic mechanical analysis of PVA/MC blend hydrogels. Polymer 42 (2001) 4271-4280
121. Li W.B., Xue F., and Cheng R.S. States of water in partially swollen poly(vinyl alcohol) hydrogels. Polymer 46 (2005) 12026-12031
122. Peppas N.A., and Stauffer S.R. Reinforced uncross-linked poly(vinyl alcohol) gels produced by cyclic freezing-thawing processes: a short review. J Control Rel 16 (1991) 305-310
123. Li J.K., Wang N., and Wu X.S. Poly(vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug delivery. J Control Rel 56 (1998) 117-126
124. Mandal T.K., Bostanian L.A., Graves R.A., and Chapman S.R. Poly(d,l-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system. Pharm Res 19 (2002) 1713-1719
125. Wang N., Wu X.S., and Li J.K. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery. Pharm Res 16 (1999) 1430-1435
126. Burczyk A., and Pielichowski J. Polyphosphazenes. Polymers 49 (2004) 486-490
127. Stewart F.F., and Harrup M.K. Phosphazene monomers from the regiospecific reaction of tert-butylhydroquinone with hexachlorocyclotriphosphazene: a new composite material precursor. J Appl Polym Sci 72 (1999) 1085-1090
128. 2. 1. Kinetics and reaction mechanism. Macromolecules 25 (1992) 1254-1258
129. Allcock H.R., Crane C.A., Morrissey C.T., Nelson J.M., Reeves S.D., Honeyman C.H., et al. "Living" cationic polymerization of phosphoranimines as an ambient temperature route to polyphosphazenes with controlled molecular weights. Macromolecules 29 (1996) 7740-7747
130. Uhrich K.E., Cannizzaro S.M., Langer R., and Shakesheff K.M. Polymeric systems for controlled drug release. Chem Rev 99 (1999) 3181-3198
131. Allcock H.R. Inorganic-organic polymers as a route to biodegradable materials. Macromol Symp 144 (1999) 33-46
132. Cohen S., Bano M.C., Visscher K.B., Chow M., Allcock H.R., and Langer R. Ionically crosslinkable polyphosphazene: a novel polymer for microencapsulation. J Am Chem Soc 112 (1990) 7832-7838
133. Payne L.G., and Andrianov A.K. Protein release from polyphosphazene matrices. Adv Drug Deliv Rev 31 (1998) 185-196
134. Allcock H.R., and Ambrosio A. Synthesis and characterization of pH-responsive poly(organophosphazene) hydrogels. ACS Symp Ser 833 (2003) 82-101
135. Seong J.Y., Jun Y.J., Kim B.M., Park Y.M., and Sohn Y.S. Synthesis and characterization of biocompatible poly(organophosphazenes) aiming for local delivery of protein drugs. Int J Pharm 314 (2006) 90-96
136. Langer R., and Vacanti J.P. Tissue engineering. Science 260 (1993) 920-926
137. Mooney D.J., and Mikos A.G. Growing new organs. Sci Am 280 (1999) 60-65
138. Khademhosseini A., Langer R., Borenstein J., and Vacanti J.P. Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci USA 103 (2006) 2480-2487
139. Vacanti J.P., Langer R., Upton J., and Marler J.J. Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev 33 (1998) 165-182
140. Tsang V.L., and Bhatia S.N. Three-dimensional tissue fabrication. Adv Drug Deliv Rev 56 (2004) 1635-1647
141. Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng 9 (2003) S5-S15
142. Lazarous D.F., Shou M., Scheinowitz M., Hodge E., Thirumurti V., Kitsiou A.N., et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94 (1996) 1074-1082
143. Epstein S.E., Fuchs S., Zhou Y.F., Baffour R., and Kornowski R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 49 (2001) 532-542
144. Xie M.H., Holcomb I., Deuel B., Dowd P., Huang A., Vagts A., et al. FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine 11 (1999) 729-735
145. Battler A., Scheinowitz M., Bor A., Hasdai D., Vered Z., Disegni E., et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 22 (1993) 2001-2006
146. Ferrara N., and Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5 (1999) 1359-1364
147. Park J.E., Keller G.A., and Ferrara N. Vascular endothelial growth-factor (VEGF) isoforms-differential deposition into the subepithelial extracellular-matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4 (1993) 1317-1326
148. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 (1999) 9-22
149. Lopez J.J., Laham R.J., Stamler A., Pearlman J.D., Bunting S., Kaplan A., et al. VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc Res 40 (1998) 272-281
150. 165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol 37 (2001) 616-623
151. Wozney J.M. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32 (1992) 160-167
152. Winn S.R., Uludag H., and Hollinger J.O. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 31 (1998) 303-318
153. Kingsley D.M. What do BMPs do in mammals-clues from the mouse short-ear mutation. Trends Genet 10 (1994) 16-21
154. Groeneveld E.H.J., and Burger E.H. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 142 (2000) 9-21
155. Massague J. TGF-β signal transduction. Annu Rev Biochem 67 (1998) 753-791
156. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor β in human disease. N Eng J Med 342 (2000) 1350-1358
157. Taipale J., Saharinen J., and Keski-Oja J. Extracellular matrix-associated transforming growth factor-β: role in cancer cell growth and invasion. Adv Cancer Res 75 (1998) 87-134
158. Pepper M.S. Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8 (1997) 21-43
159. Grad S., Kupcsik L., Gogolewski S., and Alini M. The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. Biomaterials 24 (2003) 5163-5171
160. Venugopal J., and Ramakrishna S. Applications of polymer nanofibers in biomedicine and biotechnology. Appl Biochem Biotechnol 125 (2005) 147-157
161. Park H., Temenoff J.S., Holland T.A., Tabata Y., and Mikos A.G. Delivery of TGF-β1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 26 (2005) 7095-7103
162. Holland T.A., Tessmar J.K.V., Tabata Y., and Mikos A.G. Transforming growth factor-β1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Rel 94 (2004) 101-114
163. Holland T.A., Tabata Y., and Mikos A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Rel 101 (2005) 111-125
164. Defail A.J., Chu C.R., Izzo N., and Marra K.G. Controlled release of bioactive TGF-β1 from microspheres embedded within biodegradable hydrogels. Biomaterials 27 (2006) 1579-1585
165. Elisseeff J., McIntosh W., Fu K., Blunk T., and Langer R. Controlled-release of IGF-I and TGF-β1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 19 (2001) 1098-1104
166. Giannoni P., and Hunziker E.B. Release kinetics of transforming growth factor-β1 from fibrin clots. Biotechnol Bioeng 83 (2003) 121-123
167. Yamamoto M., Takahashi Y., and Tabata Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 12 (2006) 1305-1311
168. Meinel L., Zoidis E., Zapf J., Hassa P., Hottiger M.O., Auer J A., et al. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 33 (2003) 660-672
169. Burdick J.A., Mason M.N., Hinman A.D., Thorne K., and Anseth K.S. Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. J Control Rel 83 (2002) 53-63
170. Silva G.A., Czeisler C., Niece K.L., Beniash E., Harrington D.A., Kessler J.A., et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303 (2004) 1352-1355
171. Ellis-Behnke R.G., Liang Y.X., You S.W., Tay D.K.C., Zhang S.G., So K.F., et al. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA 103 (2006) 5054-5059
172. Sakiyama-Elbert S.E., and Hubbell J.A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control Rel 69 (2000) 149-158
173. Piotrowicz A., and Shoichet M.S. Nerve guidance channels as drug delivery vehicles. Biomaterials 27 (2006) 2018-2027
174. Zisch A.H., Lutolf M.P., and Hubbell J.A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12 (2003) 295-310
175. Thomson R.C., Wake M.C., Yaszemski M.J., and Mikos A.G. Biodegradable polymer scaffolds to regenerate organs. Adv Polym Sci 122 (1995) 245-274
176. Hosaka A., Koyama H., Kushibiki T., Tabata Y., Nishiyama N., Miyata T., et al. Gelatin hydrogel microspheres enable pinpoint delivery of basic fibroblast growth factor for the development of functional collateral vessels. Circulation 110 (2004) 3322-3328
177. Peattie R.A., Rieke E.R., Hewett E.M., Fisher R.J., Shu X.Z., and Prestwich G.D. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. Biomaterials 27 (2006) 1868-1875
178. Lee K.Y., Peters M.C., and Mooney D.J. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Rel 87 (2003) 49-56
179. Andreopoulos F.M., and Persaud I. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds. Biomaterials 27 (2006) 2468-2476
180. Jeon O., Ryu S.H., Chung J.H., and Kim B.S. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Rel 105 (2005) 249-259
181. Cai S.S., Liu Y.C., Shu X.Z., and Prestwich G.D. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 26 (2005) 6054-6067
182. Lee K.Y., Peters M.C., Anderson K.W., and Mooney D.J. Controlled growth factor release from synthetic extracellular matrices. Nature 408 (2000) 998-1000
183. Lee K.Y., Peters M.C., and Mooney D.J. Controlled drug delivery from polymers by mechanical signals. Adv Mater 13 (2001) 837-839
184. Peppas N.A., and Kim B. Stimuli-sensitive protein delivery systems. J Drug Deliv Sci Technol 16 (2006) 11-18
185. Peppas N.A., Huang Y., Torres-Lugo M., Ward J.H., and Zhang J. Physicochemical, foundations and structural design of hydrogels in medicine and biology. Annu Rev Biomed Eng 2 (2000) 9-29
186. Hoffman A.S. Hydrogels for biomedical applications. Ann NY Acad Sci 944 (2001) 62-73
187. El-Sayed M.E.H., Hoffman A.S., and Stayton P.S. Smart polymeric carriers for enhanced intracellular delivery of therapeutic macromolecules. Exp Opin Biol Ther 5 (2005) 23-32
188. Jiang H.L., and Zhu K.J. Comparison of poly(aspartic acid) hydrogel and poly(aspartic acid)/gelatin complex for entrapment and pH-sensitive release of protein drugs. J Appl Polym Sci 99 (2006) 2320-2329
189. Matsusaki M., and Akashi M. Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(γ-glutamic acid)-sulfonate matrix for tissue engineering. Biomacromolecules 6 (2005) 3351-3356
190. Chen S.C., Wu Y.C., Mi F.L., Lin Y.H., Yu L.C., and Sung H.W. A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Rel 96 (2004) 285-300
191. Wu J., Su Z.G., and Ma G.H. A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate. Int J Pharm 315 (2006) 1-11
192. Liang H.F., Hong M.H., Ho R.M., Chung C.K., Lin Y.H., Chen C.H., et al. Novel method using a temperature-sensitive polymer (methylcellulose) to thermally gel aqueous alginate as a pH-sensitive hydrogel. Biomacromolecules 5 (2004) 1917-1925
193. Miyata T., Uragami T., and Nakamae K. Biomolecule-sensitive hydrogels. Adv Drug Deliv Rev 54 (2002) 79-98
194. Wang C., Kopecek J., and Stewart R.J. Hybrid hydrogels cross-linked by genetically engineered coiled-coil block proteins. Biomacromolecules 2 (2001) 912-920
195. Kopecek J. Smart and genetically engineered biomaterials and drug delivery systems. Eur J Pharm Sci 20 (2003) 1-16
196. Lasic D. Stealth liposomes. In: Benita S. (Ed). Microencapsulation Methods and Industrial Applications (1996), Marcel Dekker, New York 298-328
197. Yang L., and Alexandridis P. Physicochemical aspects of drug delivery and release from polymer based colloids. Curr Opin Colloid Interface Sci 5 (2000) 132-143
198. Barenholz Y., and Ceve G. Structure and properties of membranes. In: Baszkin A., and Norde W. (Eds). Physical Chemistry of Biological Surface (2000), Marcel Dekker, New York 171-241
199. Barenholz Y. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci 65 (2001) 66-77
200. Mouristen O.G., and Jorgenson K. A new look at lipid-membrane structure in relation to drug research. Pharm Res 15 (1998) 1507-1519
201. Mouristen O.G., and Jorgenson K. Dynamical order and disorder in lipid bilayers. Chem Phys Lipids 73 (1993) 3-25
202. Roger J.A., and Anderson K.E. The potential of liposomes in oral drug delivery system. Crit Rev Ther Drug Carrier Syst 15 (1998) 421-480
203. O'Brien D.F., Armitage B., Benedicto A., Bennett D.E., Lamparski H.G., Lee Y.S., et al. Polymerization of preformed self-organized assemblies. Acc Chem Res 31 (1998) 861-868
204. Okada J., Cohen S., and Langer R. In vitro evaluation of polymerized liposomes as an oral drug delivery system. Pharm Res 12 (1995) 576-582
205. Anderson P.M., Hanson D.C., Hasz D.E., Halet M.R., Blazar B.R., and Ochoa A.C. Cytokines in liposomes; preliminary studies with IL-1, IL-2, IL-6, GM-CSF and Interferon-γ. Cytokine 6 (1994) 92-101
206. Meyer J., Whitcomb L., and Collins D. Efficient encapsulation of proteins within liposomes for slow release in vivo. Biochem Biophys Res Commun 199 (1994) 433-438
207. Huang C. Studies on phosphatidylcholine vesicles. Formation and physical characteristics. Biochemistry 8 (1969) 344-352
208. Bangham A.D. Lipid bilayers and biomembrane. Annu Rev Biochem 41 (1973) 753-776
209. r 50000) increases uptake into liver. Biochim Biophys Acta-Biomembranes 1279 (1996) 259-265
210. Fidler I.J., Raz A., Folger W.E., Kirsh R., Bugelski P., and Poste G. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res 40 (1980) 4460-4466
211. Poste G., Bucana C., Raz A., Bugelski P., Kirsh R., and Fidler I.J. Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res 42 (1982) 1412-1422
212. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 88 (1991) 11460-11464
213. Ishida T., Harada M., Wang X.Y., Ichihara M., Irimura K., and Kiwada H. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effect of lipid dose and PEG surface density and chain length of first-dose liposome. J Control Rel 105 (2005) 305-317
214. Kim D.W., Andres M.L., Li J., Kajioka E.H., Miller G.M., Seynhaeve A.L., et al. Liposome-encapsulated tumor necrosis factor-alpha enhances the effects of radiation against human colon tumor xenografts. J Interferon Cytokine Res 21 (2001) 885-897
215. Yuyama Y., Tsujimoto M., Fujimoto Y., and Oku N. Potential usage of thermosensitive liposomes for site-specific delivery of cytokines. Cancer Lett 155 (2000) 71-77
216. Leserman L.D., Barbet J., and Kourilsky F. Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature 288 (1980) 602-604
217. Mizuno M., Yoshida J., Sugita K., Inoue I., Seo H., Hayashi Y., et al. Growth inhibition of glioma cells transfected with human γ-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res 50 (1990) 7826-7829
218. Machy P., Lewis F., McMillan L., and Jonak Z.L. Gene transfer from targeted liposomes to specific lymphoid cells by electroporation. Proc Natl Acad Sci USA 85 (1988) 8027-8031
219. Visser C.C., Stevanovic S., Voorwinden L.H., van Bloois L., Gaillard P.J., Danhof M., et al. Targeting liposomes with protein drugs to the blood-brain barrier in vitro. Eur J Pharm Sci 25 (2005) 299-305
220. Sudimack J., and Lee R.J. Targeted drug delivery via folate receptor. Adv Drug Deliv Rev 41 (2000) 147-162
221. Campbell I.G., Jones T.A., Foulkes W.D., and Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Cancer Res 51 (1991) 5329-5338
222. Reddy J.A., Haneline L.S., Srour E.F., Antony A.C., Clapp D.W., and Low P.S. Expression and functional characterization of the beta-isoform of the folate receptor on CD 34+ cells. Blood 93 (1999) 3940-3948
223. Gabizon A., Horowitz A.T., and Goren D. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjugate Chem 10 (1999) 289-298
224. Gupta B., Levchenko S.T., and Torchilin V.P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev 57 (2005) 637-651
225. Schwarze S.R., and Dowdy S.F. In vivo protein transduction; intracellular delivery of biologically active proteins, compounds and DNA. Trend Pharmacol Sci 21 (2000) 45-48
226. Hallbrink M., Floren A., Elmquist A., Pooga M., Bartfai T., and Langel U. Cargo delivery kinetics of cell-penetrating peptides. Biochem Biophys Acta 1515 (2001) 101-109
227. Pooga M., Hallbrink M., Zorko M., and Langel U. Cell penetration by transportan. FASEB J 12 (1998) 127-139
228. Oehlke J., Scheller A., Wiesner B., Krause E., Beyermann M., Klausschenz E., et al. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochem Biophys Acta 1414 (1998) 127-139
229. Green M., and Lowenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus TAT trans-activator protein. Cell 55 (1988) 1179-1188
230. Frankel A.D., and Pabo C.O. Cellular uptake of the TAT protein from human immunodeficiency virus. Cell 55 (1988) 1189-1193
231. Levchenko T.S., Rammohan R., Volodina N., and Torchilin V.P. TAT peptide-mediated intracellular delivery of liposomes. Methods Enzymol 372 (2003) 339-349
232. Torchilin V.P., Levchenko T.S., Rommohan R., Volodina N., Papahadjopoulos-Sternberg B., and D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci USA 100 (2003) 1972-1977
233. Lee E.S., Na K., and Bae Y.H. Super pH-sensitive multifunctional polymeric micelle. Nano Letters 5 (2005) 325-329
234. Steneke R.J.H., Loebis A.E., Fernandes C.M., Crommelin D.J.A., and Hennink. Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept. Pharm Res 7 (2001) 690-695
235. Feng S.S., Ruan G., and Li Q.T. Fabrication and characterizations of a novel drug delivery devices liposomes-in-microsphere (LIM). Biomaterials 25 (2004) 5181-5189
236. Machluf M., Arte R., Regev O., and Cohen S. Enhancing the immunogenicity of liposomal hepatitis B surface antigen (HBsAg) by controlling its delivery from polymeric microspheres. J Pharm Sci 89 (2000) 1550-1557
237. Fries L.F., Gordon D.M., Richards R.L., Egan J.E., Hollingdale M.R., Gross M., et al. Liposomal malaria vaccine in human; a human safe and potent adjuvant strategy. Proc Natl Acad Sci USA 89 (1992) 358-362
238. Weiner A.L. Liposomes as carriers for polypeptides. Adv Drug Deliv Rev 3 (1989) 307-341
239. Machluf M., Regev O., Peled Y., Kost J., and Cohen S. Characterization of microencapsulated liposome systems for the controlled delivery of liposome-associated macromolecules. J Control Rel 43 (1996) 35-45
240. Dai C., Wang B., Zhao W., Li B., and Wang J. Preparation and characterization in sodium alginate for protein delivery. Colloid Surf B: Biointerfaces 47 (2006) 205-210
241. Meyenberg S., Lilie H., Panzner F., and Rudolph R. Fibrin encapsulated liposomes as protein delivery system. Study on the in vitro release behavior. J Control Rel 69 (2000) 159-168
242. Oh K.S., Lee K.Y., Han S.K., Cho S.H., Kim D., and Yuk S.H. Formation of core/shell nanoparticles with a lipid core and their application as a drug delivery system. Biomacromolecules 6 (2005) 1062-1067
243. Oh K.S., Han S.K., Lee H.S., Koo H.M., Kim R.S., Lee K.Y., et al. Core/shell nanoparticles with lecithin lipid cores for protein delivery. Biomacromolecules 7 (2006) 2363-2367
244. Pekarek K.J., Dyrud M J., Ferrer K., Jong Y.S., and Mathiowitz. In vitro and in vivo degradation of double-walled polymer microspheres. J Control Rel 40 (1996) 169-178
245. Meng F., Hiemstra C., Engbers G.H.M., and Feijen Y. Biodegradable polymersomes. Macromolecules 36 (2003) 3004-3006
246. Patist A., and Zoerb H. Preservation mechanisms of trehalose in food and biosystem. Colloid Surf B: Biointerface 40 (2005) 107-113
247. Crowe J.H., Carpenter J.F., and Crowe L.M. The role of vitrification in anhydrobiosis. Annu Rev Physiol 60 (1998) 73-103
248. Kaushik J.K., and Bhat R. Why is trehalose an exceptional protein stabilizer?. J Biol Chem 278 (2003) 26458-26465
249. Firestone M.A., Wolf A.C., and Seifert S. Small-angle X-ray scattering study of the interaction of poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) triblock copolymer with lipid bilayers. Biomacromolecules 4 (2003) 15393-15497